@MrLearner
I think this is a good question. I am no means an expert but the impression is artificial bile duct engineering is very complex. A couple of factors to consider appear to be:
- Extensiveness of the damage caused by the bile duct cancer (ie how much of the liver and other parts of the body are affected).
- The corrosiveness of bile, hence how to contain it safely without damaging other organs, and how to regulate the volume of bile (ie mimic the valve).
I think quality of life is also important. IMU's approach appears to be shrinking the tumour using a combination of techniques and being able to keep most of the original tissue and support a healing process, would be the ideal case for a person in remission live a best possible life.
That is why the descriptive and diagnostic data from the IMU clinical trials will be so important. Imagine finding out the bad news of having a solid tumour cancer, and then learning that the catalyst for remission is a potential gold standard treatment involves something resembling a vaccination shot.
- Forums
- ASX - By Stock
- Media Thread
@MrLearnerI think this is a good question. I am no means an...
-
-
- There are more pages in this discussion • 1,128 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IMU (ASX) to my watchlist
(20min delay)
|
|||||
Last
4.9¢ |
Change
0.000(0.00%) |
Mkt cap ! $364.4M |
Open | High | Low | Value | Volume |
4.9¢ | 5.0¢ | 4.8¢ | $555.4K | 11.34M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
118 | 16458707 | 4.8¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
5.0¢ | 1728214 | 12 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
116 | 16443645 | 0.048 |
70 | 6992075 | 0.047 |
37 | 4755253 | 0.046 |
52 | 5221184 | 0.045 |
12 | 1153236 | 0.044 |
Price($) | Vol. | No. |
---|---|---|
0.050 | 1728214 | 12 |
0.051 | 1576328 | 10 |
0.052 | 1753192 | 11 |
0.053 | 1774938 | 12 |
0.054 | 2922460 | 12 |
Last trade - 16.10pm 21/10/2024 (20 minute delay) ? |
Featured News
IMU (ASX) Chart |
The Watchlist
LGP
LITTLE GREEN PHARMA LTD
Paul Long, Chief Executive Officer
Paul Long
Chief Executive Officer
SPONSORED BY The Market Online